ReveraGen BioPharma (United States)

VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects

Christopher R. Heier, Jesse M. Damsker, Qing Yu et al. · EMBO Molecular Medicine · 2013 · 188 citations · Full text

Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

Michela Guglieri, Paula R. Clemens, Seth J. Perlman et al. · JAMA Neurology · 2022 · 107 citations · Full text

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Laurie S. Conklin, Jesse M. Damsker, Eric P. Hoffman et al. · Pharmacological Research · 2018 · 93 citations · Full text

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy

Jean K. Mah, Paula R. Clemens, Michela Guglieri et al. · JAMA Network Open · 2022 · 79 citations · Full text

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

Edward C. Smith, Laurie S. Conklin, Eric P. Hoffman et al. · PLoS Medicine · 2020 · 78 citations · Full text